Tomoko Matsushima
Kobe, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Enhanced Clinical Utility of Molecular Budding Signature as a Recurrence Risk Determinant in Stage II and III Colon Cancer Patients.
Journal: Annals of surgical oncology
Published: January 31, 2023
Establishing a whole blood CD4+ T cell immunity measurement to predict response to anti-PD-1.
Journal: BMC cancer
Published: October 03, 2022
Correlates of neutralizing/SARS-CoV-2-S1-binding antibody response with adverse effects and immune kinetics in BNT162b2-vaccinated individuals.
Journal: Scientific reports
Published: August 26, 2021
Correlates of Neutralizing/SARS-CoV-2-S1-binding Antibody Response with Adverse Effects and Immune Kinetics in BNT162b2-Vaccinated Individuals.
Journal: medRxiv : the preprint server for health sciences
Published: August 10, 2021
A 95-gene signature stratifies recurrence risk of invasive disease in ER-positive, HER2-negative, node-negative breast cancer with intermediate 21-gene signature recurrence scores.
Journal: Breast cancer research and treatment
Published: September 26, 2020
Cyclin-Dependent Kinase Activity Correlates with the Prognosis of Patients Who Have Gastrointestinal Stromal Tumors.
Journal: Annals of surgical oncology
Published: December 28, 2014
CDK1 and CDK2 activity is a strong predictor of renal cell carcinoma recurrence.
Journal: Urologic oncology
Published: March 19, 2014
The prognostic value of apoptotic and proliferative markers in breast cancer.
Journal: Breast cancer research and treatment
Published: September 03, 2013
Novel functional assay for spindle-assembly checkpoint by cyclin-dependent kinase activity to predict taxane chemosensitivity in breast tumor patient.
Journal: Journal of Cancer
Published: March 15, 2013
Last Updated: 09/26/2026